Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.31 | 0.03 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |